Market Research Future Publish a New Report on – “US & Global Gene Therapy Market Information & Analysis (Market Data, Size, and Growth) forecast to 2024”
Genes, carried on chromosomes, are the basic physical and functional units of heredity. Notably, gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or abnormal, and whose absence or abnormality is causing the disease.
Gene therapy is turning out to be an attractive market for the companies and investors. Furthermore, the market is incessantly gaining popularity amongst the global medical community. The advent of advanced technique for gene transfer has enabled the usage of gene therapy for various new applications. The majority of the gene therapy products are in pre-clinical or clinical research. Till date, there are only four marketed drugs namely, Glybera, Neovasculogen, Gendicine, Rexin-G, and Oncorine. However, these products constitute very less revenue to the gene therapy market. The major revenue of the gene therapy market is generated from the products used in the clinical trials.
Send us a Queries related to this article @ https://www.marketresearchfuture.com/ask-sample-request/gene-therapy-market
Global US & Global Gene Therapy Market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
- Sibiono GeneTech Co. Ltd.,
- Shanghai Sunway Biotech Co. Ltd,
- Human Stem Cells Institute,
- UniQure N.V,
- Spark Therapeutics, LLC,
- Advantagene Inc,
- Bluebird Bio,
- Oxford BioMedica Plc,
- Vical Inc
Market Growth Influencer
Human gene therapy is a high growth market. The growth of the market is majorly driven by the unavailability of cure for various chronic diseases especially cancer. The medical community is striving to development a proper treatment for cancer through gene therapy. Furthermore, the market is witnessing a precipitous rise in the venture capitalist investments. For instance, recently, Philadelphia based Gene Therapy Company, Spark Therapeutics, raised US$ 72.8 Million from Sofinnova Ventures to launch a gene therapy for genetic form of blindness. Moreover, there is also an increasing incidences of chronic diseases across the globe which is another factor propelling the market growth.
However, stringent regulatory approval process for gene therapy and the high cost of the gene therapy drugs are expected to hinder the growth of the market. The cost of gene therapy is approximately 1 million. Moreover, the reimbursement scenario of gene therapy is also not well defined due to which people refrain from opting for this therapy.
Human Gene Therapy Market: Segmentation
For this study, the human gene therapy market is segmented into various segments such as commercialized therapies, product type, indication, and region.
On the basis of Commercialized Therapies, the market is segmented into
On the basis of Product Type, the market is subdivided into
- Plasmid DNA
On the basis of Indication, the market is categorized into
- Cardiovascular Diseases
- Infectious Diseases
- Neurological Disorder
- Genetic Diseases
If you have any special requirements, please let us know and we will offer you the report as you want.
For further information on this report, visit @ https://www.marketresearchfuture.com/articles/gene-therapy-market
Market Research Future introduces about the Human Gene Therapy market (Oncology, Cardiovascular, Infectious Diseases, Neurological) – Global Industry Analysis & Forecast to 2027 which mainly includes the growth drivers, trends and restraints and how the market will grow in the future across the globe. In this report, Market Research Future has focused on the current market scenario which includes market segmentation, market dynamics, and competitive landscape along with company profiles.
For more information or any query mail at email@example.com
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Name: Akash Anand
Organization: Market Research Future
Address: Market Research Future Office No. 524/528,
Phone: +1 646 845 9312
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –